VRE:NYSEVeris Residential, Inc. Analysis
Data as of 2026-06-08 - not real-time
$18.99
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Veris Residential is trading near its short‑term moving averages with a bullish price direction and increasing volume, while technical momentum remains mixed—RSI sits in the upper half of its range and the MACD histogram has just turned negative.
Fundamentally, the REIT shows solid profitability margins, a modest dividend payout supported by positive free cash flow, and a price‑to‑earnings multiple that is comfortably below the industry average. The recent Zacks upgrade to a "Buy" adds optimism, though the balance sheet is leveraged with a high debt‑to‑equity ratio. Overall, the stock appears fairly valued with limited upside, but the dividend and earnings stability make it attractive for income‑focused investors.
Fundamentally, the REIT shows solid profitability margins, a modest dividend payout supported by positive free cash flow, and a price‑to‑earnings multiple that is comfortably below the industry average. The recent Zacks upgrade to a "Buy" adds optimism, though the balance sheet is leveraged with a high debt‑to‑equity ratio. Overall, the stock appears fairly valued with limited upside, but the dividend and earnings stability make it attractive for income‑focused investors.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish price trend and support near the 20‑day SMA
- Increasing trading volume indicating stronger participation
- Zacks upgrade to a Buy rating boosting sentiment
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable dividend yield with a payout ratio under 50%
- Operating margins above 18% and solid free cash flow
- Valuation at a modest premium to fair value
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage (debt‑to‑equity over 100%) may limit future growth
- Consistent earnings and cash‑flow generation supporting dividend
- Sector exposure to residential REIT cycles and regulatory environment
Key Metrics & Analysis
Financial Health
Revenue Growth-1.60%
Profit Margin24.62%
P/E Ratio26.0
ROE5.92%
ROA1.29%
Debt/Equity109.45
P/B Ratio1.5
Op. Cash Flow$76.8M
Free Cash Flow$109.3M
Industry P/E32.5
Technical Analysis
TrendBullish
RSI64.6
Support$18.93
Resistance$19.01
MA 20$18.97
MA 50$18.93
MA 200$16.30
MACDBearish
VolumeIncreasing
Fear & Greed Index88.8
Valuation
Fair Value$0.84
Target Price$19.75
Upside/Downside4.00%
GradeFair
TypeBlend
Dividend Yield1.69%
Risk Assessment
Beta0.11
Volatility1.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.